Targeting Periostin Expression Makes Pancreatic Cancer Spheroids More Vulnerable to Natural Killer CellsDidem Karakaş, Engı̇n Ulukaya|Biomedicines|2023Cited by 6
eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironmentDidem Karakaş|Cell Death and Disease|2025Cited by 5